Connor, Clark & Lunn Investment Management (CC&L)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-25,996
| Closed | -$97K | – | 1258 |
|
|
2021
Q2 | $97K | Buy |
+25,996
| New | +$97K | ﹤0.01% | 946 |
|
|
2021
Q1 | – | Sell |
-76,745
| Closed | -$262K | – | 1125 |
|
|
2020
Q4 | $262K | Buy |
+76,745
| New | +$262K | ﹤0.01% | 798 |
|
|
2020
Q3 | – | Sell |
-255,880
| Closed | -$865K | – | 1170 |
|
|
2020
Q2 | $865K | Sell |
255,880
-87,994
| -26% | -$297K | 0.01% | 644 |
|
|
2020
Q1 | $801K | Buy |
343,874
+141,049
| +70% | +$329K | 0.01% | 608 |
|
|
2019
Q4 | $738K | Sell |
202,825
-5,525
| -3% | -$20.1K | 0.01% | 599 |
|
|
2019
Q3 | $1.73M | Buy |
208,350
+31,225
| +18% | +$259K | 0.01% | 439 |
|
|
2019
Q2 | $1.53M | Buy |
177,125
+148,575
| +520% | +$1.28M | 0.01% | 498 |
|
|
2019
Q1 | $305K | Buy |
+28,550
| New | +$305K | ﹤0.01% | 753 |
|
|
2018
Q4 | – | Sell |
-50,790
| Closed | -$853K | – | 1068 |
|
|
2018
Q3 | $853K | Buy |
+50,790
| New | +$853K | ﹤0.01% | 593 |
|
|
2017
Q2 | – | Sell |
-108,304
| Closed | -$704K | – | 984 |
|
|
2017
Q1 | $704K | Sell |
108,304
-94,396
| -47% | -$614K | ﹤0.01% | 561 |
|
|
2016
Q4 | $898K | Sell |
202,700
-9,600
| -5% | -$42.5K | 0.01% | 506 |
|
|
2016
Q3 | $991K | Sell |
212,300
-121,800
| -36% | -$569K | 0.01% | 468 |
|
|
2016
Q2 | $2.2M | Sell |
334,100
-87,625
| -21% | -$576K | 0.02% | 354 |
|
|
2016
Q1 | $2.68M | Sell |
421,725
-191,800
| -31% | -$1.22M | 0.02% | 299 |
|
|
2015
Q4 | $3.7M | Buy |
613,525
+233,225
| +61% | +$1.41M | 0.03% | 247 |
|
|
2015
Q3 | $2.27M | Buy |
380,300
+342,200
| +898% | +$2.05M | 0.02% | 287 |
|
|
2015
Q2 | $261K | Buy |
38,100
+6,700
| +21% | +$45.9K | ﹤0.01% | 516 |
|
|
2015
Q1 | $191K | Buy |
31,400
+5,300
| +20% | +$32.2K | ﹤0.01% | 507 |
|
|
2014
Q4 | $181K | Buy |
+26,100
| New | +$181K | ﹤0.01% | 533 |
|